Scientific Sessions 2024  /  Applying Advances in Risk Prediction to PREVENT CV Disease  /  External validation of PREVENT in a large health system
Logo

American Heart Association

  107
  0

Final ID:

External validation of PREVENT in a large health system

  • Go, Alan  ( KAISER PERMANENTE NORTHERN CAL , Pleasanton , California , United States )
    • Author Disclosures:
    Alan Go: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers-Squibb:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Applying Advances in Risk Prediction to PREVENT CV Disease

Monday, 11/18/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Case: managing a patient with discordant ASCVD and HF risk

Ostrominski John

Using risk prediction to guide the use of non-statin pharmacotherapies

Pandey Ambarish, Berg David

More abstracts from these authors:
Discussant

Tison Geoffrey, Go Alan

Incidence of Diagnosed Atrial Fibrillation in Community-Based Asian American, Native Hawaiian and other Pacific Islander Subpopulations: Findings from the PANACHE Study

Go Alan, Ambrosy Andrew, Parikh Rishi, Tan Thida, Howick Connor, Alexeeff Stacey, Lo Joan, Daida Yihe

You have to be authorized to contact abstract author. Please, Login
Not Available